Caption: 
An SwRI scientist conducts cytotoxicity testing of potential drug compounds identified by SwRI’s Rhodium™ virtual screening tool as having a high probability of efficacy against the coronavirus with minimal adverse side effects. Rhodium recently evaluated more than 40 million drug compounds in a week, with help from Department of Defense supercomputers, as part of a $1.9 million, one-year contract to support efforts to develop a COVID-19 treatment from the Henry M. Jackson Foundation for the Advancement of Military Medicine. 

Credit: 
Courtesy of Southwest Research Institute